APA

Jonasch E., Kumar U. N., Linette G. P., Hodi F. S., Soiffer R. J., Ryan B. F., Sober A. J., Mihm M. C., Tsao H., Langley R. G., Cosimi B. A., Gadd M. A., Tanabe K. K., Souba W., Haynes H. A., Barnhill R., Osteen R. & Haluska F. G. (20001026). Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma. : Cancer journal (Sudbury, Mass.).

Chicago

Jonasch E, Kumar U N, Linette G P, Hodi F S, Soiffer R J, Ryan B F, Sober A J, Mihm M C, Tsao H, Langley R G, Cosimi B A, Gadd M A, Tanabe K K, Souba W, Haynes H A, Barnhill R, Osteen R and Haluska F G. 20001026. Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma. : Cancer journal (Sudbury, Mass.).

Harvard

Jonasch E., Kumar U. N., Linette G. P., Hodi F. S., Soiffer R. J., Ryan B. F., Sober A. J., Mihm M. C., Tsao H., Langley R. G., Cosimi B. A., Gadd M. A., Tanabe K. K., Souba W., Haynes H. A., Barnhill R., Osteen R. and Haluska F. G. (20001026). Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma. : Cancer journal (Sudbury, Mass.).

MLA

Jonasch E, Kumar U N, Linette G P, Hodi F S, Soiffer R J, Ryan B F, Sober A J, Mihm M C, Tsao H, Langley R G, Cosimi B A, Gadd M A, Tanabe K K, Souba W, Haynes H A, Barnhill R, Osteen R and Haluska F G. Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma. : Cancer journal (Sudbury, Mass.). 20001026.